Start Submission Become a Reviewer

Reading: Cardiovascular Disease Risk Assessment: Insights from Framingham

Download

A- A+
Alt. Display

Review

Cardiovascular Disease Risk Assessment: Insights from Framingham

Authors:

Ralph B. D’Agostino Sr. ,

Mathematics and Statistics Department, Boston University, Boston, MA; Framingham Study, Framingham, MA; Biostatistics Department, Boston University, Boston, MA, US
X close

Michael J. Pencina,

Mathematics and Statistics Department, Boston University, Boston, MA; Framingham Study, Framingham, MA; Biostatistics Department, Boston University, Boston, MA, US
X close

Joseph M. Massaro,

Mathematics and Statistics Department, Boston University, Boston, MA; Framingham Study, Framingham, MA; Biostatistics Department, Boston University, Boston, MA, US
X close

Sean Coady

National Heart, Lung, and Blood Institute, Rockville, MD, US
X close

Abstract

Cardiovascular disease (CVD) is among the leading causes of death and disability worldwide. Since its beginning, the Framingham study has been a leader in identifying CVD risk factors. Clinical trials have demonstrated that when the modifiable risk factors are treated and corrected, the chances of CVD occurring can be reduced. The Framingham study also recognized that CVD risk factors are multifactorial and interact over time to produce CVD. In response, Framingham investigators developed the Framingham Risk Functions (also called Framingham Risk Scores) to evaluate the chance or likelihood of developing CVD in individuals. These functions are multivariate functions (algorithms) that combine the information in CVD risk factors such as sex, age, systolic blood pressure, total cholesterol, high-density lipoprotein cholesterol, smoking behavior, and diabetes status to produce an estimate (or risk) of developing CVD or a component of CVD (such as coronary heart disease, stroke, peripheral vascular disease, or heart failure) over a fixed time, for example, the next 10 years. These estimates of CVD risk are often major inputs in recommending drug treatments such as cholesterol-lowering drugs.
How to Cite: D’Agostino Sr. RB, Pencina MJ, Massaro JM, Coady S. Cardiovascular Disease Risk Assessment: Insights from Framingham. Global Heart. 2013;8(1):11–23. DOI: http://doi.org/10.1016/j.gheart.2013.01.001
35
Views
20
Downloads
79
Citations
Published on 01 Mar 2013.
Peer Reviewed

Downloads

  • PDF (EN)

    comments powered by Disqus